NYSE ARCA | ETF
The fund invests at least 80% of its net assets in financial instruments, that, in combination, provide 3X daily leveraged exposure to the index, consistent with the fund's investment objective.
The index is a modified equal-weighted index that is designed to measure performance of the stocks, defined as pharmaceutical and medical stocks, comprising the S&P Total Market Index that are classified in the GICS pharmaceuticals sub-industry.
The fund is non-diversified.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| FTIXX | Goldman Sachs Financial Square Treasury Instruments Fund Institutional Shares | 12.95% | ||
| LBPH | Longboard Pharmaceuticals Inc | Healthcare | Biotechnology | 2.99% |
| ITCI | Intracellular Th | Healthcare | Drug Manufacturers - Specialty & Generic | 2.94% |
| CTLT | Catalent Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 2.92% |
| CBAY | Cymabay Therapeu | Healthcare | Biotechnology | 2.88% |
| TARS | Tarsus Pharmaceuticals Inc | Healthcare | Biotechnology | 2.27% |
| LLY | Eli Lilly and Company | Healthcare | Drug Manufacturers - General | 2.17% |
| JAZZ | Jazz Pharmaceuticals PLC | Healthcare | Biotechnology | 2.16% |
| NUVB | Nuvation Bio Inc | Healthcare | Biotechnology | 2.00% |
| CRNX | Crinetics Pharmaceuticals Inc | Healthcare | Biotechnology | 1.90% |
| ELAN | Elanco Animal Health | Healthcare | Drug Manufacturers - Specialty & Generic | 1.88% |
| AXSM | Axsome Therapeutics Inc | Healthcare | Biotechnology | 1.86% |
| LGND | Ligand Pharmaceuticals Incorporated | Healthcare | Biotechnology | 1.86% |
| MRK | Merck & Company Inc | Healthcare | Drug Manufacturers - General | 1.80% |
| JNJ | Johnson & Johnson | Healthcare | Drug Manufacturers - General | 1.80% |
| AVDL | Avadel Pharmaceuticals PLC | Healthcare | Drug Manufacturers - Specialty & Generic | 1.77% |
| CORT | Corcept Therapeutics Incorporated | Healthcare | Biotechnology | 1.67% |
| RPRX | Royalty Pharma Plc | Healthcare | Biotechnology | 1.67% |
| LQDA | Liquidia Technologies Inc | Healthcare | Biotechnology | 1.65% |
| HRMY | Harmony Biosciences Holdings | Healthcare | Biotechnology | 1.60% |